Company Announcements In March, Transgenomic expanded its license with the Dana-Farber Cancer Institute to include Ice COLD-PCR (CO-amplification at Lower Denaturing temperature PCR), a technique that further extends sensitivity of mutation detection, and an exclusive license for analysis of COLD-PCR products by Pyrosequencing. WaferGen Biosystems and NuGEN Technologies agreed to codevelop and comarket integrated workflows […]
Waltham, MA 5/5/11—PerkinElmer has acquired Geospiza, a developer of software systems for the management of genetic analysis and laboratory workflows delivered through a cloud-computing environment. Financial details were not disclosed. PerkinElmer stated that the acquisition supports its Next Generation DNA Sequencing and Analysis Services offerings (see IBO 2/15/11). “The acquisition of Geospiza, along with existing […]
Company Announcements Biosearch Technologies licensed access to its BHQ, CAL Fluor and Quasar patents to DuPont Qualicon in October 2010 and is now manufacturing Scorpions primer oligonucleotides for DuPont. In November 2010, MDxHealth licensed its methylation-specific PCR (MSP) technology to Takara Bio for the scientific research market. QuantaLife closed $17.2 million in Series B financing […]
Digital PCR (dPCR) extends traditional PCR into the realm of real-time quantitative PCR. It is a method used to directly quantify and clonally amplify nucleic acids. It is an accurate and sensitive technique that counts individual nucleic acid molecules for applications such as detection of rare mutations and quantifying viral load, gDNA, cDNA, plasmids or […]
Company Announcements Biosearch Technologies entered into a new licensing agreement in August, extending QIAGEN’s existing rights to Scorpions primer assays to include the right to manufacture, catalog and sell them into the research, applied and infectious disease–testing markets. QIAGEN also gained rights to market labeled probes based on Biosearch’s Black Hole Quencher dyes for qPCR […]
Company Announcements Takara Bio granted QIAGEN GmbH a license in April to make, use and sell LA PCR–related products. QIAGEN NV acquired rights in May to 70 real time PCR–based molecular food safety tests developed by the Institute for Product Quality. The first kits will be available in the fourth quarter. The company plans to […]
Company Announcements Cepheid’s 2009 product revenues increased 0.6% to $170.6 million (see IBO 1/31/10). Adjusted net loss was $5.0 million, compared to $7.1 million the year before. Clinical and Industrial sales increased 28.5% and 24.1% to make up 70% and 12% of sales. BioThreat and Partner sales declined 30.8% and 70.3% to make up 15% […]
Company Announcements Transgenomic licensed Dana-Farber Cancer Institute’s Cold-PCR technology, including the exclusive right to commercialize it combined with Sanger sequencing and the right to use it for mitochondrial DNA analysis. Cepheid named Nicolaas Arnold executive vice president of Worldwide Commercial Operations in October 2009. Most recently, he was regional vice president for Siemens Healthcare Diagnostics […]
Company Announcements Monsanto is developing field tests for biotech crops using TwistDx’s Recombinase Polymerase Amplification (RPA) technology. BioTrove announced a collaboration with the FDA to investigate the use of its OpenArray Standardized NanoArray PCR (SNAP) gene expression profiling system for detection of pathogens in the US’s blood supply. In September, QIAGEN acquired additional licenses from […]
Company Announcements Idaho Technology licensed its reagents or methods using SYBR Green I technology and melting curve analysis for real-time PCR to Thermo Fisher Scientific and Finnzymes Oy. Idaho Technology signed an agreement with Microbiology International for the exclusive distribution of its R.A.P.I.D. LT Food Security System in the US. Transgenomic completed a licensing option […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
